Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
D000577:Amides / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use; D005260:Female; D007093:Imidazoles / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D013997:Time Factors
D000577:Amides; D000970:Antineoplastic Agents; D001391:Azo Compounds; D007093:Imidazoles